Acute anxiolytic effects of cocaine: the role of test latency and activity phase

Pharmacology, Biochemistry, and Behavior
C P MüllerM A De Souza Silva

Abstract

The emotional effects of the initial consumption of cocaine can have a strong influence on the subsequent use of this drug. Several studies in rodents using long test latencies have reported anxiogenic effects of cocaine. Anxiogenesis, however, would seem to contradict cocaine's well known rewarding effects and its abuse liability. The present study was set up to shed light on conditions that influence cocaine's consequences, namely the time after administration and active vs. resting test phase. The aim of the first experiment was to investigate the effects of cocaine (0, 5, 10, 15 mg/kg, i.p.) on anxiety-related behavior in rats in their active phase with a short test latency of 10 min. In the open field test cocaine had an anxiolytic-like effect, which was confirmed in the elevated plus-maze test. A second experiment investigated the effects of cocaine after a latency of 30 min in animals in their active vs. resting phase. After 30 min significant anxiolytic-like effects were no longer observed in either of the paradigms, irrespective of the activity phase. This and other studies suggest that after first exposure cocaine has acute anxiolytic effects, which rapidly decline, and, may eventually reverse to a longer lasting anxi...Continue Reading

References

Mar 1, 1978·The American Journal of Psychiatry·R K Siegel
Oct 1, 1992·Pharmacology, Biochemistry, and Behavior·R Rogerio, R N Takahashi
Feb 15, 1991·Biological Psychiatry·T D Geracioti, R M Post
Jan 1, 1991·Psychopharmacology·A Ettenberg, T D Geist
Jan 1, 1989·Life Sciences·D J Fontana, R L Commissaris
May 1, 1989·Pharmacology, Biochemistry, and Behavior·B CostallE S Onaivi
Jan 1, 1981·Progress in Neuro-psychopharmacology·G T Shearman, H Lal
Feb 1, 1995·Trends in Pharmacological Sciences·G R Dawson, M D Tricklebank
Apr 16, 1998·Psychopharmacology·J R Mantsch, N E Goeders
May 28, 1998·Neuroreport·R K SchwartingJ P Huston
Jan 12, 1999·Neuroscience and Biobehavioral Reviews·S M WeissC T Dourish
Nov 5, 1999·Pharmacology, Biochemistry, and Behavior·R J BlanchardD C Blanchard
Jun 27, 2002·Proceedings of the National Academy of Sciences of the United States of America·Carolina AbarcaRainer Spanagel
Feb 26, 2003·European Journal of Pharmacology·Laetitia Prut, Catherine Belzung
Jul 17, 2003·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Tolga UzHari Manev
Aug 18, 2004·Science·Véronique Deroche-GamonetPier Vincenzo Piazza
Apr 11, 2006·European Journal of Pharmacology·Maria A De Souza SilvaMarilia Barros
Dec 13, 2006·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·E ErhardtH M T Barros
Feb 24, 2007·Progress in Neurobiology·Christian P MüllerMaria A De Souza Silva

❮ Previous
Next ❯

Citations

Apr 10, 2013·Psychopharmacology·Zu-In SuAaron Ettenberg
Nov 15, 2011·The Behavioral and Brain Sciences·Christian P Müller, Gunter Schumann
Oct 21, 2015·Genes, Brain, and Behavior·D BelinJ W Dalley
Mar 1, 2012·Behavioural Brain Research·Maria do Carmo de Oliveira CitóFrancisca Cléa Florenço de Sousa
Jan 18, 2011·Brain Research Bulletin·Martin E PumChristian P Müller
Apr 24, 2010·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·C Velázquez-SánchezJ J Canales
Apr 14, 2016·International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience·E MacúchováR Šlamberová

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.